Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683]

Bioorg Med Chem Lett. 2021 Apr 1:37:127836. doi: 10.1016/j.bmcl.2021.127836. Epub 2021 Feb 13.
No abstract available

Publication types

  • Published Erratum